Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2019
|
Online Access: | http://eprints.uanl.mx/15810/1/12.pdf |
Description not available. |